 Connection
Chad Rusthoven to Immunotherapy
This is a "connection" page, showing publications Chad Rusthoven has written about Immunotherapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.391 |
|
|
|
-
Levy A, Rusthoven CG, Brown PD, Le Péchoux C, Faivre-Finn C. Prophylactic Cranial Irradiation for Patients With SCLC-A New Perspective in the Immunotherapy Era. J Thorac Oncol. 2025 03; 20(3):395-398.
Score: 0.153
-
Foster CC, Sher DJ, Rusthoven CG, Verma V, Spiotto MT, Weichselbaum RR, Koshy M. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis. Radiat Oncol. 2019 Jan 28; 14(1):18.
Score: 0.102
-
Stokes WA, Binder DC, Jones BL, Oweida AJ, Liu AK, Rusthoven CG, Karam SD. Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy. J Neuroimmunol. 2017 12 15; 313:118-122.
Score: 0.093
-
Bansal P, Rusthoven C, Boumber Y, Gan GN. The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. Future Oncol. 2016 Dec; 12(23):2713-2727.
Score: 0.021
-
Jackson MW, Rusthoven CG, Jones BL, Kamdar M, Rabinovitch R. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma. Am J Hematol. 2016 May; 91(5):476-80.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|